Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Zachary Warriner

Trauma Surgery Lexington, KY Medical Doctor

NPI 1225396799 CMS profile 1024765

Uk Healthcare, 740 S Limestone Ste L104, Lexington, KY 40536

Open in the dashboard

General payments

$68,818

129 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$184,883 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Zachary Warriner of Lexington, KY is reported in the CMS Open Payments database as having received $68,818 across 129 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $184,883 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Trauma Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,918 12
2024 General $39,596 61
2023 General $16,951 33
2022 General $2,880 18
2021 General $350 4
2020 General $124 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Zachary Warriner
  • Trauma Surgery median
  • Middle half of Trauma Surgery
  • National median

In program year 2025, general payments to Zachary Warriner were reported at $8,918. Among 762 Trauma Surgery profiles paid that year, the median was $280 and the middle half received between $87 and $1,585.

Show as a table
Year Zachary Warriner Trauma Surgery median Middle half National median
2019 $0 $153 $56–$644 $163
2020 $124 $123 $39–$342 $114
2021 $350 $142 $45–$556 $132
2022 $2,880 $172 $59–$732 $149
2023 $16,951 $213 $83–$1,200 $160
2024 $39,596 $237 $86–$1,280 $164
2025 $8,918 $280 $87–$1,585 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Medical Device Business Services, Inc. $57,906 54 payments
  2. CSL Behring $6,034 23 payments
  3. Davol Inc. $2,124 15 payments
  4. DePuy Synthes Sales Inc. $1,061 12 payments
  5. Zimmer Biomet Holdings, Inc. $422 5 payments
  6. Becton, Dickinson and Company $344 6 payments
  7. Boston Scientific Corporation $269 3 payments
  8. Atricure, Inc. $217 3 payments
  9. HemoSonics LLC $154 1 payment
  10. Baxter Healthcare $124 1 payment
  11. Other $163 6 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Consulting Fee $48,984 8 payments
  2. Travel and Lodging $14,776 43 payments
  3. Food and Beverage $5,058 78 payments
Products named General payments · program years 2020–2025
  1. MATRIXRIB $54,501 49 payments
  2. Phasix Mesh $2,468 21 payments
  3. MATRIXORTHOGNATHIC $1,998 6 payments
  4. AdvantageRib $337 4 payments
  5. ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) $217 3 payments
  6. SPYGLASS $157 2 payments
  7. QUANTRA QPLUS SYSTEM $154 1 payment
  8. QUNATRA QPLUS SYSTEM $154 1 payment
  9. TRUMATCH $127 1 payment
  10. FLOSEAL $124 1 payment
  11. Other $633 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

17

Median for General Surgery: 59

Drug cost

$1,217

Median for General Surgery: $393

Branded share of claims

100%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Lactated Ringers Ringer's Solution,lactated Brand 17 $1,217

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 59 billing codes

Paid by Medicare

$49,916

Medicare's payments for the services billed

Medicare patients

157

Average age 72

Services billed

316

86 women, 71 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 61%
Diabetes 46%
Chronic kidney disease 40%
COPD 39%
Ischemic heart disease 38%
Depression 37%
Heart failure 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

129 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Trauma Surgery in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record